ROLE OF THE APOB GENE POLYMORPHISM (c.12669G>A, p.Gln4154Lys) IN CORONARY ARTERY DISEASE IN THE INDIAN PUNJABI POPULATION
Sharma R1,*, Mahajan M2, Singh B1, Singh G3, Singh P3
*Corresponding Author: Ritu Sharma, Department of Biochemistry, Government Medical College, Circular Road, Amritsar-143001, Punjab, India; Tel.: +91-183-257-3637; Fax: +91-183-242-6506: E-mail: ritu_gmc@ rediffmail.com
page: 35

RESULTS

The subjects under study had either the R+R+ genotype or R+R genotype. No individual with homozygous mutant alleles, i.e., RR, was identified (Figure 1). The frequency of R+ and R alleles was calculated (with an allele counting method) in control subjects as well as in CAD patients. The frequency of the R allele was significantly higher (p <0.05) in CAD patients when compared to controls. In order to study the association of the R allele with CAD, variations in serum lipids, lipoprotein cholesterol and apoB levels of CAD patients and control subjects with different apoB genotypes were investigated (Table 1). Total cholesterol, triglycerides, very low-density lipo-protein-cholesterol (VLDL-C), lowdensity lipoprotein-cholesterol (LDL-C) and highdensity lipoprotein-cholesterol (HDL-C) levels did not differ significantly in the subjects, whether they were CAD patients or controls carrying the R+R+ or R+R APOB genotype. The data were analyzed after segregating subjects on the basis of age and gender. However, CAD patients with the R+R genotype had significantly raised (p <0.05) serum apoB levels as compared to those having the R+R+ genotype. Raised serum apoB levels indicate the predominance of small dense LDL particles that are more prone to oxidation. The MDA-LDL levels and apoB carbonyl content of LDL did not differ significantly in CAD patients with different APOB genotypes (Table 2). A similar trend was observed in Log triglyceride/ high-density lipoprotein-cholesterol (HDL-C) value which was taken as an index of LDL particle size. Overall, CAD patients had increased predominance of small dense LDL particles resulting in their increased oxidation. However, this observation was independent of APOB genotypes.



Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006